...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: First Dosing v "Actively Recruiting" ?

I am more concerned about first dosing.  seems it should have happened by now.

This was to be an "open" study.

My good thoughts go out to the first patient.  May you have great success and an early release.

And hopefully we have a news release! sidebar.

Share
New Message
Please login to post a reply